Can the VAP Test detect the metabolic syndrome?
The atherogenic lipid triad of low HDL, high triglycerides, and small, dense LDLalso known as the metabolic syndromeis described in NCEP ATP III guidelines as a widespread and underdiagnosed health problem. It is crucial to understand that atherosclerosis begins developing in these patients, and they maysuffer coronary events, before their blood sugar starts to rise. The expanded lipid panel may be superior to fasting insulin levels and glucose tolerance tests for detecting the metabolic syndrome, as well as providing a better guide to therapy.
